3692 HANSON
1. Behavior, abbreviation EMA35 test and Horizontal Line
2. The stock chart is stronger than the INDEX
3. Operating results grow in the second half of 2023 after partnering with allies, allowing sales to grow rapidly.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.86 HKD
3.62 B HKD
11.16 B HKD
1.11 B
About HANSOH PHARMACEUTICAL GROUP CO LTD
Sector
CEO
Hui Juan Zhong
Headquarters
Shanghai
Website
Founded
2015
FIGI
BBG00P78Y7N1
Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. Its products include oncology, anti-infective, anti-diabetic, gastrointestinal, and cardiovascular drugs. The company was founded by Hui Juan Zhong on December 2, 2015 and is headquartered in Shanghai, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
HNSP5116270
Hansoh Pharmaceutical Group Company Limited 0.0% 22-JAN-2026Yield to maturity
2.80%
Maturity date
Jan 22, 2026
Explore more bonds
Frequently Asked Questions
The current price of 3692 is 18.26 HKD — it has increased by 4.08% in the past 24 hours. Watch HANSOH PHARMACEUTICAL GROUP CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange HANSOH PHARMACEUTICAL GROUP CO LTD stocks are traded under the ticker 3692.
3692 stock has risen by 2.88% compared to the previous week, the month change is a −17.70% fall, over the last year HANSOH PHARMACEUTICAL GROUP CO LTD has showed a 25.76% increase.
We've gathered analysts' opinions on HANSOH PHARMACEUTICAL GROUP CO LTD future price: according to them, 3692 price has a max estimate of 29.56 HKD and a min estimate of 17.64 HKD. Watch 3692 chart and read a more detailed HANSOH PHARMACEUTICAL GROUP CO LTD stock forecast: see what analysts think of HANSOH PHARMACEUTICAL GROUP CO LTD and suggest that you do with its stocks.
3692 reached its all-time high on Jan 21, 2021 with the price of 46.70 HKD, and its all-time low was 9.42 HKD and was reached on Aug 21, 2023. View more price dynamics on 3692 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
3692 stock is 5.86% volatile and has beta coefficient of 0.80. Track HANSOH PHARMACEUTICAL GROUP CO LTD stock price on the chart and check out the list of the most volatile stocks — is HANSOH PHARMACEUTICAL GROUP CO LTD there?
Today HANSOH PHARMACEUTICAL GROUP CO LTD has the market capitalization of 105.99 B, it has increased by 3.60% over the last week.
Yes, you can track HANSOH PHARMACEUTICAL GROUP CO LTD financials in yearly and quarterly reports right on TradingView.
HANSOH PHARMACEUTICAL GROUP CO LTD is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
3692 earnings for the last half-year are 0.49 HKD per share, whereas the estimation was 0.42 HKD, resulting in a 17.95% surprise. The estimated earnings for the next half-year are 0.24 HKD per share. See more details about HANSOH PHARMACEUTICAL GROUP CO LTD earnings.
HANSOH PHARMACEUTICAL GROUP CO LTD revenue for the last half-year amounts to 6.99 B HKD, despite the estimated figure of 6.70 B HKD. In the next half-year revenue is expected to reach 5.76 B HKD.
3692 net income for the last half-year is 2.95 B HKD, while the previous report showed 2.15 B HKD of net income which accounts for 37.47% change. Track more HANSOH PHARMACEUTICAL GROUP CO LTD financial stats to get the full picture.
HANSOH PHARMACEUTICAL GROUP CO LTD dividend yield was 1.35% in 2023, and payout ratio reached 34.83%. The year before the numbers were 0.67% and 19.69% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has 9.12 K employees. See our rating of the largest employees — is HANSOH PHARMACEUTICAL GROUP CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HANSOH PHARMACEUTICAL GROUP CO LTD EBITDA is 5.09 B HKD, and current EBITDA margin is 30.46%. See more stats in HANSOH PHARMACEUTICAL GROUP CO LTD financial statements.
Like other stocks, 3692 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HANSOH PHARMACEUTICAL GROUP CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HANSOH PHARMACEUTICAL GROUP CO LTD technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HANSOH PHARMACEUTICAL GROUP CO LTD stock shows the buy signal. See more of HANSOH PHARMACEUTICAL GROUP CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.